Background—ICD therapy is established therapy for secondary prevention after aborted
sudden death or ventricular tachycardia. Long-term data on the incidence of appropriate and …

Background—The prevalence rates and influencing factors for deployment of primary
prevention implantable cardioverter defibrillators (ICDs) among subjects who eventually …

Objectives To construct a risk score out of baseline variables to estimate the risk of death
without prior implantable cardioverter defibrillator (ICD) in primary prevention ICD patients …

Implantable cardioverter-defibrillators (ICDs) reduce sudden cardiac death risk and improve
survival in patients with a history of life-threatening arrhythmia or cardiac arrest (secondary …

BACKGROUND: The implantable cardioverter defibrillator (ICD) is the therapy of choice in
patients at risk for sudden cardiac death in both primary and secondary prevention …

Abstract Aims The EUropean Comparative Effectiveness Research to Assess the Use of
Primary ProphylacTic Implantable Cardioverter-Defibrillators (EU-CERT-ICD), a prospective …

We commonly use absolute risk to determine candidacy for therapy in cardiovascular
disease. For example, in patients with atrial fibrillation, annualized stroke estimates guide …

Background—Implantable cardioverter-defibrillators (ICDs) are increasingly used for primary
prevention after randomized, controlled trials demonstrating that they reduce the risk of …

Aims The beneficial effects of implantable cardioverter defibrillators (ICDs) in primary and
secondary prevention patients are well established. However, data on potential differences …

Background: Despite major advances in treating patients with severe heart failure, deciding
who should receive an implantable cardiac defibrillator (ICD) remains challenging …